Benjamin Li
Mar 5, 2010

Mindshare, Aegis Media, OMD and ZenithOptimedia vie for Xian-Janssen Pharmaceutical media planning account in China

BEIJING - Johnson & Johnson owned Xian-Janssen Pharmaceutical Company has called a media planning review in China.

Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Mindshare, Aegis Media, OMD and ZenithOptimedia are understood to be involved in the pitch.

According to agency sources, the account is a “good size and meaningful” and is worth an estimated US$15 million.

OMD holds the media buying account for Johnson & Johnson. The agency won the business in 2007, which also includes Shanghai Johnson & Johnson Pharmaceuticals and Johnson & Johnson Vision Care.

Motilium and Daktarin are among Xian-Janssen Pharmaceutical's main products in China.


 
Source:
Campaign China

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

Jan 29, 2026

Gemini 3 becomes the default model for AI Overviews

A pair of updates from Google see the tech giant attempt to gain a further foothold in the battle for AI-powered search supremacy.

Jan 29, 2026

Google criticised after blocking measurement ...

YouTube owner sent a 'cease and desist' letter to Barb and Kantar Media.

Jan 29, 2026

Inside Campaign Connect Indonesia: what matters to ...

Candid conversations on growth, AI and the cultural trade-offs of scaling brands, with more than 100 marketers in the room.

Jan 29, 2026

Meta hits $200 billion revenue milestone on ...

Meta reports double‑digit year-on-year revenue growth, with advertising once again accounting for almost all of the top line.